Products
Investing
Resources
Support
Piramal Pharma Limited (PPLPHARMA)
₹211.05
INR-12.57(-5.62%)
As of April 30, 2025 10:00:00 AMValuation Metrics
Market Cap
Total market value of the company's outstanding shares
₹29029.42 Cr
Enterprise Value
Total value of the company including debt and excluding cash
₹30728.03 Cr
P/E Ratio (TTM)
Price to Earnings ratio based on trailing 12 months
671.28
Forward P/E
Price to Earnings ratio based on forecasted earnings
56.66
PEG Ratio
Price/Earnings to Growth ratio
-6.15
Price to Sales (TTM)
Price to Sales ratio based on trailing 12 months
3.24
Financial Metrics
Gross Margin
Gross profit as a percentage of revenue
63.44%
Operating Margin
Operating income as a percentage of revenue
6.39%
Return on Equity
Net income as a percentage of shareholders' equity
0.23%
Revenue (TTM)
Total revenue over trailing 12 months
₹8949.47 Cr+12.5%
EBITDA
Earnings Before Interest, Taxes, Depreciation, and Amortization
₹1571.60 Cr
EPS (TTM)
Earnings Per Share over trailing 12 months
₹0.32-63.6%
Balance Sheet
Total Cash
Total cash and short-term investments
₹408.41 Cr
Total Debt
Total short-term and long-term debt
₹4786.41 Cr
Debt to Equity
Total debt as a percentage of shareholders' equity
60.53%
Stock Information
52 Week Range
Lowest and highest stock price over the past 52 weeks
₹136.1 - ₹307.9
Beta
Measure of stock's volatility compared to the market
0.10
Shares Outstanding
Total number of shares issued by the company
₹131.80 Cr
Dividends & Splits
Forward Dividend Yield
Expected dividend yield based on forward dividend rate
0.05%
Trailing Dividend Yield
Dividend yield based on trailing 12 months
NA
Payout Ratio
Percentage of earnings paid as dividends
33.33%